Patient-reported outcomes in high-risk HR+/HER2-early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study - García-Sáenz, José Angel; Marmé, Frederik; Untch, Michael; Bonnefoi, Herve; Kim, Sung-Bae; Bear, Harry; Mc Carthy, Nicole; Gelmon, Karen; Martin, Miguel; Kelly, Catherine M.; Reimer, Toralf; Toi, Masakazu; et al. (European journal of cancer, 2024)
Im Text ist "B" hochgestellt